HIT

Health In Tech, Inc. (HIT) - Q2 2025 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Health In Tech, Inc. (HIT) is an insurance technology platform operating as a marketplace for self-funded benefits plans and stop-loss insurance. The company facilitates transactions between small business employers, licensed brokers, third-party administrators (TPAs), and insurance carriers. HIT is classified as a smaller reporting company and an emerging growth company. As of June 30, 2025, the company served 942 business clients with 24,839 enrolled employees across 41 states.

Key Financial Metrics

Note: The filing does not provide a specific debt balance other than operating lease liabilities ($174,356 total) and a promissory note receivable (asset) of $800,000. There is no long-term debt listed on the balance sheet.

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 86.2% year-over-year for the three months ended June 30, 2025, and 71.1% for the six-month period. This was driven by a 30% increase in enrolled employees (24,839 vs. 19,101 in 2024).
• Revenue Mix Shift: Revenues from fees (SMR) grew 114.8% (Q3) and 92.2% (YTD), while revenues from the HI Card subsidiary dropped to zero in 2025 compared to $767,840 in Q3 2024.
• Cost of Revenues: Increased significantly to 32.3% of revenue (Q3) and 32.7% (YTD) from 19.5% and 19.4% in the prior year periods, attributed to higher captive management fees for new products.
• Balance Sheet: "Other receivables" surged by $3.35 million to $3.85 million due to the March 2025 purchase of Deferred Administrative Surplus rights. Total liabilities increased by $3.16 million year-over-year, driven by payables related to this purchase and operational expansion.
• Profitability: Net income margin improved to 6.7% (Q3) and 6.6% (YTD) compared to 6.7% and 4.4% in the prior year periods, respectively.

Guidance, Outlook, and Risks

• Outlook: Management cites strong demand for new product offerings and positive feedback from beta testing with mid-to-large employers. The company expects to continue investing in technology (eDIYBS 3.0) and expanding its broker/TPA network.
• Unusual Items: The company recorded a $955,743 refund liability (contra-revenue) related to a variable consideration adjustment with a specific carrier. This amount is expected to be finalized in May 2026.
• Risks:
  • Customer Concentration: One stop-loss carrier ("Carrier A") accounted for 28.2% of Q3 2025 revenues and 32.8% of accounts receivable.
  • Supplier Concentration: One primary service provider accounted for 80.3% of cost of revenues in Q3 2025.
  • Collection Risk: Significant exposure to the collectability of "Deferred Administrative Surplus" purchased in 2023 and 2025. As of June 30, 2025, collection rates on reconciled amounts were 79% (2023 purchase) and 37% (2025 purchase).
  • Regulatory & Cyber: Risks related to data privacy, cybersecurity, and compliance with insurance regulations.

Investor Verification Checklist

• Deferred Administrative Surplus Collectability: Verify the actual collection rates and timeline for the $17.4M face value surplus purchased in March 2025, given the low initial collection rate (37%) on reconciled amounts.
• Carrier Concentration: Assess the risk of losing "Carrier A," which represents over 28% of revenue and nearly one-third of accounts receivable.
• Variable Consideration Liability: Monitor the $955,743 refund liability related to the carrier adjustment clause and its potential impact on future revenue recognition.
• Cost Structure: Analyze the sustainability of the rising cost of revenue (32%+ of revenue) versus the historical 19% level as the company scales new products.
• Stock-Based Compensation: Review the impact of significant stock-based compensation ($1.2M for six months ended June 30, 2025) on future cash burn and dilution.